Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vascular Access Centers is a healthcare services business focused on outpatient vascular access management for dialysis patients, rather than a drug-development biotech company. The organization operates specialized centers that provide minimally invasive procedures to evaluate, maintain, declot, revise, and restore dialysis access, including arteriovenous fistulas, grafts, catheters, and related venous access procedures. The name is also used by local operating entities such as Vascular Access Centers of Illinois, indicating that the requested term refers more to a clinical services network/brand than to a single R&D-stage biopharma issuer. Historically, this business area was associated with American Access Care, which was acquired by Fresenius Medical Care in 2011 and integrated into Fresenius's vascular care operations. As a result, the company is best understood as a commercial outpatient vascular care provider serving ESRD and dialysis-access patients in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vascular Access Centers.